XML 57 R47.htm IDEA: XBRL DOCUMENT
v3.23.1

Segment Information (Restated) (Tables) | 3 Months Ended
--- | ---
Jul. 02, 2022
Segment Reporting [Abstract] |
Schedule of Segment Information | The following tables present our segment information for the 26 weeks ended July 2, 2022 and July 3, 2021 (in $000's):
|  | Thirteen Weeks Ended |  |  | Twenty Six Weeks Ended |
|  | July 2, 2022 |  |  | July 3, 2021 |  |  | July 2, 2022 |  |  | July 3, 2021 |
|  | (as restated) |  |  |  |  |  | (as restated) |  |  |  |
Revenues |  |  |  |  |  |  |  |  |  |  |  |
Biotechnology |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |
Recycling |  |  | 10,538 |  |  |  | 8,606 |  |  |  | 19,862 |  |  |  | 17,278 |
Discontinued operations |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Total Revenues |  | $ | 10,538 |  |  | $ | 8,606 |  |  | $ | 19,862 |  |  | $ | 17,278 |
Gross profit |  |  |  |  |  |  |  |  |  |  |  |
Biotechnology |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |
Recycling |  |  | 1,649 |  |  |  | 1,743 |  |  |  | 3,502 |  |  |  | 3,164 |
Discontinued operations |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Total Gross profit |  | $ | 1,649 |  |  | $ | 1,743 |  |  | $ | 3,502 |  |  | $ | 3,164 |
Operating Income (loss) |  |  |  |  |  |  |  |  |  |  |  |
Biotechnology |  | $ | (110 | ) |  | $ | (808 | ) |  | $ | (352 | ) |  | $ | (1,050 | )
Recycling |  |  | (1,147 | ) |  |  | (1,099 | ) |  |  | (1,993 | ) |  |  | (2,027 | )
Operating loss from continuing operations |  |  | (1,257 | ) |  |  | (1,907 | ) |  |  | (2,345 | ) |  |  | (3,077 | )
Discontinued operations |  |  | 10,239 |  |  |  | (945 | ) |  |  | 10,235 |  |  |  | (1,884 | )
Total Operating income (loss) |  | $ | 8,982 |  |  | $ | (2,852 | ) |  | $ | 7,890 |  |  | $ | (4,961 | )
Depreciation and amortization |  |  |  |  |  |  |  |  |  |  |  |
Biotechnology |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |
Recycling |  |  | 137 |  |  |  | 110 |  |  |  | 268 |  |  |  | 218 |
Depreciation and amortization from continuing operations |  |  | 137 |  |  |  | 110 |  |  |  | 268 |  |  |  | 218 |
Discontinued operations |  |  | — |  |  |  | 935 |  |  |  | 2 |  |  |  | 1,872 |
Total Depreciation and amortization |  | $ | 137 |  |  | $ | 1,045 |  |  | $ | 270 |  |  | $ | 2,090 |
Interest expense, net |  |  |  |  |  |  |  |  |  |  |  |
Biotechnology |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |
Recycling |  |  | 61 |  |  |  | 125 |  |  |  | 253 |  |  |  | 198 |
Discontinued operations |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Total Interest expense, net |  | $ | 61 |  |  | $ | 125 |  |  | $ | 253 |  |  | $ | 198 |
Net income (loss) before benefit from income taxes |  |  |  |  |  |  |  |  |  |  |  |
Biotechnology |  | $ | (110 | ) |  | $ | (808 | ) |  | $ | (352 | ) |  | $ | (1,050 | )
Recycling |  |  | (1,363 | ) |  |  | (2,992 | ) |  |  | 127 |  |  |  | (1,353 | )
Net loss before benefit from income taxes |  |  | (1,473 | ) |  |  | (3,800 | ) |  |  | (225 | ) |  |  | (2,403 | )
Discontinued operations |  |  | 10,351 |  |  |  | (974 | ) |  |  | 10,317 |  |  |  | (1,871 | )
Total Net income (loss) before benefit from income taxes |  | $ | 8,878 |  |  | $ | (4,774 | ) |  | $ | 10,092 |  |  | $ | (4,274 | )
|  | As of July 2, 2022 |  |  | As of January 1, 2022 |
Assets |  |  |  |  |  |
Biotechnology |  | $ | — |  |  | $ | — |
Recycling |  |  | 25,706 |  |  |  | 15,058 |
Discontinued operations |  |  | — |  |  |  | 107 |
Total Assets |  | $ | 25,706 |  |  | $ | 15,165 |
Intangible assets |  |  |  |  |  |
Biotechnology |  | $ | — |  |  | $ | — |
Recycling |  |  | 345 |  |  |  | 268 |
Discontinued operations |  |  | — |  |  |  | — |
Total Intangible assets |  | $ | 345 |  |  | $ | 268 |

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration